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SUMMARY
In vitro gametogenesis is the process of making germline cells from human pluripotent stem cells. 
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(PGCs), which in vivo are specified during the peri-implantation window of human development. 
Here, we show that human PGC (hPGC) specification begins at day 12 post-fertilization. Using 
single-cell RNA sequencing of hPGC-like cells (hPGCLCs) differentiated from pluripotent stem 
cells, we discovered that hPGCLC specification involves resetting pluripotency toward a 
transitional state with shared characteristics between naive and primed pluripotency, followed by 
differentiation into lineage-primed TFAP2A+ progenitors. Applying the germline trajectory to 
TFAP2C mutants reveals that TFAP2C functions in the TFAP2A+ progenitors upstream of 
PRDM1 to regulate the expression of SOX17. This serves to protect hPGCLCs from crossing the 
Weismann’s barrier to adopt somatic cell fates and, therefore, is an essential mechanism for 
successfully initiating in vitro gametogenesis.
Graphical Abstract
In Brief
Using genetics, genomics, and single-cell RNA-seq, Chen et al. characterize the human germline 
trajectory, revealing two pluripotent cell transitions during primordial germ cell specification. 
They reveal the identity of primordial germ cell progenitors and show that TFAP2C prevents 
gastrulation and amnion-like fate at the point of primordial germ cell specification.
INTRODUCTION
More than a century ago, the German biologist August Weismann proposed the germplasm 
theory of heredity in which he postulated that germ cells of animals contain an essential 
hereditary substance that passes from one generation to the next, now known to be DNA 
(Weismann, 1893). As a part of his theory, the concept of ‘‘Weismann’s barrier’’ was also 
established (Weismann 1893). This is not a physical barrier but a model that proposes that 
hereditary information flows only through germline cells and not somatic cells of the body. 
This is important because without germline specification, the outcome is infertility, a disease 
that affects around 10% of humans of reproductive age. Understanding or possibly 
overcoming infertility requires a human model that recapitulates all stages of germline cell 
development, including how Weismann’s barrier is first established with the specification of 
primordial germ cells (PGCs) and somatic cells in the embryo. Human pluripotent stem cells 
and the differentiation of PGC-like cells (PGCLCs) serve this purpose.
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Specification of PGCs in animals involves two different strategies. One involves pre-
formation, which occurs in the model organisms Xenopus, zebrafish, Drosophila, and 
Caenorhabditis elegans (Extavour and Akam, 2003; Williamson and Lehmann, 1996). In 
these organisms, rare cells of the newly fertilized embryo inherit molecules produced by the 
female germline (oocyte), bestowing upon these embryonic cells the maintenance of 
germline cell identity. In contrast, cells that do not inherit these maternal molecules from the 
oocyte after fertilization become somatic cells, thus irreversibly crossing Weismann’s barrier 
and losing the capacity to contribute to the germline. For animals that specify germ cells, 
each generation by induction, such as mouse, pig, horse, rabbit, and human, Weismann’s 
barrier encompasses an additional step, which involves an initial fate restriction from 
totipotency to pluripotency, and then around the time of embryo implantation and 
gastrulation, PGCs are induced from peri-implantation cell precursors (Magnúsdóttir and 
Surani, 2014; Tang et al., 2016). The identity of these precursors in humans is completely 
unknown. As PGC specification progresses, the remaining embryonic precursors cross 
Weismann’s barrier to become somatic cells. In mouse, where mouse PGC (mPGC) 
induction is well studied, it has been reported that mPGCs are induced at embryonic day 6.5 
(E6.5) by bone morphogenetic protein 4 (BMP4) signaling to the Wnt family member 3 
(WNT3)-primed epiblast cells (Ohinata et al., 2009). The maintenance of germline identity 
downstream of BMP4 signaling involves the transcription factor network, including 
transcription factors (TFs) PRDM14, PRDM1 (also known as BLIMP1), and TFAP2C, with 
PRDM1 functioning upstream of TFAP2C to repress somatic cell fate and maintain mPGC 
identity (Magnúsdóttir and Surani, 2014; Magnúsdóttir et al., 2013; Nakaki et al., 2013; 
Ohinata et al., 2005; Weber et al., 2010; Yamaji et al., 2008).
Recent studies using the differentiation of human PGCLCs (hPGCLCs) from human 
pluripotent stem cells have revealed that the TF network required to specify and maintain 
human PGC (hPGC) fate is different from the mouse (Chen et al., 2017; Irie et al., 2015; 
Kojima et al., 2017, Sasaki et al., 2015). For example, SOX17 is required for hPGCLC 
specification, whereas in mouse it is not (Irie et al., 2015). In mPGCs, TFAP2C functions 
downstream of PRDM1 to repress somatic cell differentiation genes (Ohinata et al., 2005). 
However, in hPGCLC differentiation from PRDM1 mutants, TFAP2C expression levels are 
unaffected in the PRDM1 mutant hPGCLCs relative to controls (Sasaki et al., 2015). One 
human-specific role for TFAP2C in hPGCLCs involves the opening of naive-specific 
enhancers and the acquisition of naive-like pluripotency (Chen et al., 2018). An alternate but 
not necessarily mutually exclusive role for TFAP2C is to repress somatic cell gene 
expression in PRDM1-positive hPGCLC precursors and, therefore, to keep cells within 
Weismann’s barrier (Kojima et al., 2017). However, this result is predicated on the 
assumption that PRDM1 is expressed in hPGCLC precursors before TFAP2C, and also that 
PRDM1 is not expressed by the somatic cells of the aggregates. The only way to address this 
is to evaluate the germline and somatic cell trajectories from the pluripotent state through to 
the specification of hPGCLCs. Recently, single-cell RNA sequencing (scRNA-seq) has been 
widely used to map differentiation trajectories and to discover new cell types without known 
markers (Poirion et al., 2016; Stegle et al., 2015). Capitalizing on this approach to identify 
the precursors of hPGCs in the peri-implantation window, we performed scRNA-seq of more 
than 100,000 individual cells during hPGCLC specification to model the molecular events in 
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hPGC specification by using an adapted developmental trajectory detection algorithm named 
time constraint URD (tcURD). Through this work, we uncovered the human germline 
trajectory and discovered the identity of potential peri-implantation progenitors for hPGCs.
RESULTS
Tracing hPGCs during Peri-implantation Embryogenesis and in hESC-based hPGCLC 
Induction
Using human embryo attachment culture (Deglincerti et al., 2016; Shahbazi et al., 2016), we 
evaluated whether ex vivo hPGCs could be identified before primitive streak formation and, 
therefore, the feasibility of using the human embryo attachment culture model to identify 
hPGC progenitors. Under California state law, human embryo attachment culture is legally 
allowed up to day 12 post-fertilization, which is 2 days before the International Consensus 
of day 14 or before primitive streak formation. To trace ex vivo hPGCs, we first confirmed 
the co-expression of NANOG, SOX17, and TFAP2C (N/S/T) as being restricted to hPGCs 
(Gkountela et al., 2015; Guo et al., 2015; Tang et al., 2015) (Figures S1A and S1B). Next, 
we thawed a total of 127 day 5 or day 6 post-fertilization human blastocysts; twenty-four h 
after thawing, these blastocysts were considered day 6 or day 7, respectively. From this 
cohort, we performed whole-mount immunofluorescence followed by confocal imaging and 
3D reconstruction of 78 human embryos from day 6 to day 12 (Figure 1A; Table S1). We 
discovered N/S/T triple-positive putative ex vivo hPGCs at day 12 post-fertilization in 2/26 
embryos (Figures 1B and S1C; Video S1; Table S2). N/S/T triple-positive cells were not 
identified at any of the reminaing 52 embryos at either days 10–11 or days 6–7 (Figures S1D 
and S1E). Instead, in the pre-implantation blastocyst, the TFAP2C protein was expressed in 
all cells, whereas NANOG- and SOX17-positive cells were mutually exclusive, marking the 
pre-implantation epiblast (Pre-EPI) and hypoblast cells, respectively (Figure S1E). Taken 
together, these observations suggest that hPGC specification defined as N/S/T triple-positive 
cells in the peri-implantation embryo begins at around day 12 post-fertilization in humans 
before primitive streak formation.
Given that less than 10% of human blastocysts at day 12 had evidence of N/S/T triple-
positive hPGCs, it would be difficult to discriminate the identity of hPGC precursors in this 
system without using large numbers of intact human embryos consented to research. 
Therefore, we used the differentiation of human embryonic stem cells (hESCs) into 
hPGCLCs by generating disorganized 3D aggregates in the presence of BMP4 and other 
cytokines (Sasaki et al., 2015) (Figure 1C). We used the two-step method of differentiation 
starting from primed pluripotent stem cells and first differentiating through an incipient 
mesoderm-like cell (iMELC) intermediate, as this approach has been successfully used by 
different groups to generate hPGCLCs from primed hESCs and hiPSCs (Sasaki et al.,2015; 
Chen et al., 2017; Chen et al., 2018; Yokobayashi et al., 2017; Kojima et al., 2017). Given 
the known variability in hPGCLC competency between independently derived pluripotent 
stem cell lines (Chen et al., 2017; Yokobayashi et al., 2017), we designed the experiment to 
evaluate hPGCLC specification in a highly germline competent hESC line (UCLA2) and a 
hESC line with significantly lower competency (UCLA1) (Figures 1D and 1E). These hESC 
lines were derived under identical conditions from individual blastocysts that were provided 
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by the same embryo donors (Diaz Perez et al., 2012). We discovered rare and yet 
reproducible N/S/T triple-positive hPGCLCs at day 1 of aggregate differentiation after 
exposure to BMP4 in both cell lines, with an increase in the percentage of triple-positive 
hPGCLCs emerging at day 2 in the highly competent UCLA2 line relative to UCLA1 
(Figure 1F).
To better characterize the dynamics of germline specification, we applied scRNA-seq with 
10x Genomics to hESCs, iMeLCs (incipient mesoderm-like cells), and aggregate cells at 
days 1–4 with two biological replicates for both UCLA1 and UCLA2 cell lines (Zheng et al., 
2017) (Table S3). In total, we sequenced 85,309 cells with high quality to uncover the 
germline trajectory and explored the progenitors involved in establishing germline cell fate 
(Table S4). To identify the cell populations at each time point, we used canonical correlation 
analysis (CCA) for batch correction of the two biological replicates at each time point within 
each cell line and applied uniform manifold approximation and projection (UMAP) to 
visualize the distribution of single cells throughout the entire differentiation time course 
(Figures 1G, 1H, and S1F). Specified hPGCLCs were indicated by the germline-specific 
gene NANOS3 (Gkountela et al., 2013; Butler et al., 2018; McInnes et al., 2018) (Figures 
1G and 1H). Consistently, more NANOS3-positive hPGCLCs were present in UCLA2 than 
UCLA1. Interestingly, we observed clear branches of connected cell clusters following the 
temporal order of PGCLC differentiation in the 2D maps from both UCLA1 and UCLA2 
(Figures 1G and 1H).
Mapping the Human Germline Trajectory by scRNA-seq
To precisely map the human germline trajectory, we first identified cells quadruple-positive 
for NANOG, SOX17, TFAP2C, and the germline-specific gene NANOS3 (with log-
transformed-normalized unique molecular identifier (UMI) counts of >0.5 for NANOG, 
SOX17, TFAP2C, and NANOS3) in UCLA1 and UCLA2 as hPGCLCs (Figures 2A, 2B, 
S2A, and S2B). The emergence of distinct quadruple cells was identified at day 1 and 
persistent during day 2 to day 4 differentiation (Figures 2A and 2B). These observations 
indicate that hPGCLC specification occurs within the first 24–48 h of BMP exposure, and 
UCLA2 responds more rapidly and efficiently relative to UCLA1.
To identify differentiation trajectories unbiasedly without using previously known lineage 
markers, we applied the computational trajectory detection method URD to the scRNA-seq 
data (Farrell et al., 2018). URD is mainly built on connecting cells with nearest neighbors in 
terms of transcriptome similarity under the assumption that the transcriptome of a cell 
changes progressively during differentiation. It has been reported that hPGCs and hPGCLCs 
regain pluripotency after specification (Chen et al., 2018), which may connect the specified 
hPGCLCs to hESCs directly. To avoid these possible artificial connections, we adapted URD 
with a constraint that cells could only be connected to its neighbors from the same, the 
previous, or the next time points (STAR Methods), and we applied this time constraint URD 
(tcURD) to predict germline trajectory (Figuress 2C, 2D, S2A, and S2B). This analysis 
revealed that in the less-competent UCLA1 hESC line, a subset of iMeLCs (yellow) had 
already exited from the branched cellular trajectory, to beome cells equivalent to visceral/
yolk sac endoderm (Figure 2C). However, in UCLA2, all iMeLCs retain competency to 
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differentiate toward either hPGCLCs or somatic cells including endoderm as well as other 
peri-implantation lineages (Figure 2D). Therefore, unlike UCLA1, at the time of BMP4 
exposure, more UCLA2 iMeLCs are still within Weismann’s barrier and are, therefore, 
competent for hPGCLC specification. Notably, PRDM1 is not restricted only to germline 
trajectory but is also present in endoderm cells (Figures S2C and S2D).
To map the somatic lineages differentiating together with the hPGCLCs in the 3D 
disorganized aggregates, we compared our differentiation trajectories to the cynomolgus 
(cyno) macaque per-implantation embryo scRNA-seq datasets (Nakamura et al., 2016) and 
amnion-like cells (AMLCs) from 3D embryo models (Zheng et al., 2019). Basically, we 
identified the signature genes for each annotated cell type in cyno scRNA-seq data and 
AMLCs, followed by calculating the signature score in each human cell across the germline 
trajectory to score the ends of the branches at day 4 (STAR Methods). This analysis revealed 
that the somatic cells in the disorganized aggregates include yolk sac endoderm/primitive 
endoderm and a variety of somatic cell types equivalent to trophoblast (TE), gastrulating 
cells (Gast), amnion, and extra-embryonic mesenchyme (EXMC) (Figures 2C and 2D). This 
result indicates that the 3D disorganized aggregates from independently derived hESC lines 
have the potential to differentiate into a variety of peri-implantation cell types together with 
the germline cells in the presence of BMP4.
Given there was only one germline specification trajectory along with other somatic lineages 
(Figures 2C, 2D, S2C, and S2D) in both UCLA1 and UCLA2, we used the trajectory from 
each cell line to trace the peri-implantation embryonic progenitors to the human germline. 
Figures S2
hPGCLCs Are Specified through a Pluripotent State with Both Naive and Primed 
Characteristics
Next, we focused only on the germline trajectory. Using pseudotime analysis of the cells 
extracted from the germline trajectory, we first explored the dynamics of hPGC specification 
genes (NANOG, SOX17, TFAP2C, and NANOS3) together with the pluripotent TFs SOX2 
and OCT4 (Also known as POU5F1). OCT4 is expressed in all cells of the trajectory. 
NANOG is also expressed throughout the germline trajectory with notable downregulation 
toward the end of day 1, followed by a subsequent upregulation at day 2 during hPGCLC 
specification. SOX2 repression in the germline trajectory begins at the time of iMeLC 
induction and is more pronounced at the end of day 1, concomitant with upregulation of the 
germline specifier SOX17. TFAP2C expression was dynamic in the germline trajectories of 
UCLA1 and UCLA2, being upregulated during day 1 in UCLA1 and UCLA2 (Figures 3A 
and S3A).
To map the in vitro germline trajectory back to in vivo embryogenesis, we again used the 
scRNA-seq data of cyno embryos (Nakamura et al., 2016), with a focus on the pluripotent 
stages of development, including inner cell mass (ICM), Pre-EPIs, post-implantation early 
epiblasts (PostE-EPIs), and post-implantation late epiblasts (PostL-EPIs). As previously 
reported, we discovered that undifferentiated UCLA2 (Figure 3B) and UCLA1 (Figure S3B) 
hESCs highly expressed the signatures of the cyno PostE-EPI and PostL-EPI with primed 
pluripotency (Nakamura et al., 2016). However, to our surprise, the iMeLCs within the 
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germline trajectory of UCLA2 and UCLA1 reset their pluripotency status to a state that 
correlates with both cyno ICM and Pre-EPI (naive) and PostE-EPI and PostL-EPI (primed) 
(Figures 3B and S3B). This result suggests that in 24 h of exposure to the cytokines in 
iMeLC media, the hESCs initiate a partial reversion toward naive-like pluripotency states 
found in the pre-implantation primate embryo while retaining primed state characteristics. 
To confirm the pluripotent state in germline trajectory iMeLCs, we also defined naive and 
primed signatures by using scRNA-seq data of human naive and primed hESCs (Messmer et 
al., 2019). Consistently, iMeLCs in the germline trajectory showed signatures of both naive 
and primed hESCs (Figures 3C and S3C). Thus, we termed the transitional pluripotent state 
of iMeLCs in germline trajectory as a ‘‘germinal pluripotent state,’’ as they are competent to 
give rise to hPGCs in addition to somatic lineages (Figure 2C and 2D). Furthermore, we 
discovered TFs that are enriched in germinal pluripotent cells which are expressed at lower 
levels in naive and primed pluripotent states (Figure 3D). To find the in vivo counterparts of 
embryonic cells in this transitional germinal pluripotent state, we applied scRNA-seq to day 
12 human embryos. We identified 13 cells annotated as epiblasts based on the cyno 
embryonic cells (Nakamura et al., 2016) (Figure 3E). Within these 13 cells, we discovered 4 
cells that show signatures of primed hESCs, naive hESCs, and iMeLCs in germline 
trajectory, indicating they are possible in vivo embryonic cells with germinal pluripoteny 
(Figure 3F).
Human PGC Specification Transitions through a TFAP2A+ Progenitor with Both Amnion 
and Gastrulation Signatures
There are currently two hypotheses for the origin of hPGCs in amniotes with bilaminar 
embryonic discs. Using the non-human primate cyno macaque as a model, cynoPGCs are 
identified in the amnion at E11 (Sasaki et al., 2016). However, in the porcine (p), porcine 
PGCs (pPGCs) were first identified in pre-mesendoderm cells in the region of the posterior 
primitive streak (Kobayashi et al., 2017). To further map the human germline trajectory back 
to in vivo embryogenesis, we next tracked the putative amnion-related genes (TFAP2A, 
GATA3, and CDX2) in the germline trajectory (Shao et al., 2017a, 2017b). Strikingly, 
TFAP2A is upregulated for approximately 24 h during day 1, together with GATA3 and 
CDX2 (Figures 4A and 4B). Repression of TFAP2A, GATA3, and CDX2 genes then mark 
the beginning of hPGCLC specification. Genes related to gastrulation, EOMES and T (also 
known as BRACHYURY), were highly and transiently upregulated at the beginning of day 1 
in the UCLA2 germline trajectory. In contrast, the less-competent UCLA1 line exhibited 
only modest upregulation of EOMES and T (Figures 4A and 4B). Notably, TFAP2A is also 
expressed in gastrulating cells during cyno embryogenesis (Figure S4A). These observations 
suggest that hPGC specification originates from a transient population of TFAP2A-
expressing progenitors that exhibit both amnion- and gastrulation-like TF identity, with cells 
exhibiting more TFAP2A+ gastrulation-like identity in the earlier stages of UCLA2 relative 
to UCLA1 germline trajectories. Given that clear clusters of NANOG/SOX17/TFAP2C/
NANOS3 quadruple-positive cells are first shown at day 2 (Figures 2A and 2B), we termed 
the day 1 cells in germline trajectory as germline progenitors.
To better infer the relationships of the D1 progenitor cells to the peri-implantation embryo, 
we utilized the scRNA-seq dataset of the recently published organized 3D human embryo 
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model, with a focus on the AMLCs and day 2 (D2) hPGCLCs. The 3D embryo model was 
created by exposing the H9 hESC line to BMP4 for 48 h by using microfluidics, which 
results in the generation of posteriorized embryonic-like sacs with AMLCs, pre-gastrula 
cells, and hPGCLCs (Zheng et al., 2019). For gastrulation cell identity, we utilized the 
annotated gastrulating cells from cyno peri-implantation embryo (Sasaki et al., 2016). 
(Figures 4C and S3B). This analysis reveals that TFAP2A+ day 1 progenitors are strongly 
enriched in cells with gastrulation identity throughout day 1 and that AMLC identity is also 
particularly strong at the end of day 1 just prior to N/S/T and NANOS3 positive hPGCLC 
specification (Figures 4C and S4B). Notably the D2 hPGCLCs from the 3D embryo model 
strongly resemble the day 2 to day 3 hPGCLCs in the germline trajectory, whereas the early 
cynoPGCs (ecPGCs) resemble day 4 hPGCLCs generated in the aggregates (Figures 4C and 
S4B). Given that the hPGCLCs from the 3D embryo model at 48 h map the closest to the 
day 2–day 3 hPGCLCs in the germline trajectory from the 3D-disorganized aggregates, this 
result suggests that regardless of whether 3D-modeled embryos or 3D-disorganized 
aggregates are used to generate hPGCLCs, the identity of the hPGCLC 48 h (or 2 days) after 
BMP4 exposure is very similar. Given that the current approach for creating 3D-modeled 
embryos can only be sustained for 48–72 h before the system collapses, the disorganized 
aggregates provide a slightly extended opportunity to consolidate hPGCLC fate to one that is 
closer to ecPGCs found in vivo. (Figures 4D and S4C).
TFAP2C Functions Upstream of SOX17 in Human Germline Specification
Next, we focused on the cells in the germline trajectory to decipher the gene regulatory 
network associated with the establishment of hPGC fate. To do this, we first identified 
germline trajectory differentially expressed genes (gtDEGs) as the union of pseudotime 
correlated genes, and DEGs across stages in the germline trajectory (STAR Methods). About 
3,000 gtDEGs were detected and grouped into 10 and 12 clusters in UCLA1 and UCLA2, 
respectively, based on their expression profiles across the trajectory (Figures 5A and S5A). 
A clear wave of dynamic gene expression was observed in both UCLA1 and UCLA2 from 
undifferentiated hESCs to hPGCLCs at day 4 (Figures 5A and S5A). To understand the 
regulatory mechanism, we predicted TFs based on the motif enrichment at the promoter 
regions of genes in each cluster as upstream regulators (Figures 5A and S5A; STAR 
Methods). From this analysis, we identified expected TFs known to be responsible for 
hPGCLC specification, including SOX17, TFAP2C, PRDM1, and EOMES (Figures 5A and 
S5A). In addition, we identified TFAP2A at day 1–2 of aggregate differentiation as well as 
the TFs ID3, ID4, and TBX3 (Figures 5A and S5A) and others. Notably, germline trajectory 
TFs shared by UCLA1 and UCLA2 include germline related (TFAP2C, SOX17, and 
PRDM1), pluripotency related (NANOG, POU5F1, and KLF4), amnion/gastrulation related 
(TFAP2A, CDX2, and GATA3), and BMP4 signaling related (ID1, ID2, ID3, SMAD6, 
MSX1, and MSX2) (Figures 5A and S5A; Table S5).
An analysis of the TF regulatory network at the time of hPGCLC specification indicates that 
SOX17 may be a putative target of TFAP2C (Figures 5B and S5B–S5D). To test this, we 
compared chromatin accessibility measured by ATAC-seq (Chen et al., 2018) and TFAP2C 
binding measured by chromatin immunoprecipitation sequencing (ChIP-seq) in hESCs, 
iMeLCs, and day 4 aggregates. To identify potential distal regulatory elements, we also 
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performed H3K27ac ChIP-seq in day 4 hPGCLCs isolated using ITGA6/EPCAM (Figure 
5C). We discovered that TFAP2C is bound to the SOX17 promoter in hESCs, iMeLCs, and 
day 4 cells. However, SOX17 mRNA is only upregulated in hPGCLCs (Figure 5C). This 
observation suggests that the TFAP2C promoter binding at the SOX17 locus is not sufficient 
to induce the dynamic upregulation of SOX17 at the time of hPGCLC specification. 
Integrating the H3K27ac and TFAP2C ChIP-seq data, we propose that although TFAP2C is 
always bound to the SOX17 promoter, it is the binding of TFAP2C to distal regulatory sites 
that are also coordinately enriched in H3K27ac in hPGCLCs to enable SOX17 expression at 
the point of hPGCLC specification (Figure 5C).
TFAP2C Safeguards Germ Cell Fate in the Germline Trajectory
TFAP2C is critical for hPGCLC formation but is not necessary for hESC self-renewal or the 
differentiation of iMeLCs (Chen et al., 2018; Kojima et al., 2017). To evaluate the role of 
TFAP2C in the germline trajectory, we performed scRNA-seq of TFAP2C −/− cells at 6 time 
points (hESCs, iMeLCs, aggregates at days 1 to 4, 19,808 cells sequenced) and compared 
this to the single cells from UCLA1 wild-type cells, which is the genetic background used to 
make the TFAP2C mutant (Figure 6A). As shown in UMAP, most of cells from TFAP2C−/− 
are aligned with wild-type cells across the six differentiation time points (Figures 6B and 
6C). In contrast, the germline cluster marked by NANOS3 is composed almost entirely of 
wild-type cells (Figure 6C and 6D). The rare TFAP2C−/− cells in the hPGCLC cluster 
defined by UMAP were analyzed further and compared to wild-type UCLA1 hPGCLCs. 
This analysis showed that TFAP2C−/− hPGCLCs failed to repress genes associated with 
somatic cell embryonic morphogenesis (Figure S6A), suggesting that TFAP2C functions as 
predicted in specified hPGCLCs to prevent cells from exiting the germline to adopt a 
somatic cell fate (Kojima et al., 2017).
To evaluate whether TFAP2C functions earlier in the germline trajectory, we applied tcURD 
analysis to the merged wild-type and TFAP2C−/− data to identify blades that were highly 
enriched in wild-type cells (blue) or mutant cells (red) (Figures 6E and 6F). These data show 
a very distinct blade (red dashed line box in Figure 6F) composed of mostly TFAP2C−/− 
cells, that branches from the common day 1 progenitor (blue dashed line box in Figure 6F) 
to hPGCLCs (labeled as hPGCLC in Figure 6F). This TFAP2C−/− blade is negative for the 
hPGCLC markers NANOS3 and SOX17 (Figures 6G and 6H) and instead expresses somatic 
genes consistent with posterior primitive streak progenitors, including MIXL1, T, HOXB5, 
HAND1, GATA6, FOXF1, and MESP2. (Figures 6I, 6J, and S6C). To determine the 
consequence of failing to express TFAP2C in the TFAP2A common progenitors, we 
identified differentially expressed genes between wild-type and the TFAP2C mutant cells in 
the progenitor population, and discovered that TFAP2C−/− cells fail to upregulate SOX17 
and downregulate SOX2 (Figure S6D). In contrast, the endoderm trajectory was composed 
of equivalent percentages of both wild-type and TFAP2C mutant cells, and these cells 
expressesed SOX17, indicating that the regulation of SOX17 expression by TFAP2C is 
unique to the germline at this stage in development (Figure 6H). To examine pluripotency 
and hPGC identity in wild-type and TFAP2C−/− cells, we evaluated the signatures from cyno 
Pre-EPI, PostL-EPI, and ecPGCs in day 1 to day 4 cells of the germline trajectory. No 
difference was detected in day 1 wild-type and TFAP2C−/− cells; however, starting from day 
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2, TFAP2C−/− cells were lower in pre-EPI pluripotency and ePGC identity but higher in 
PostL-EPI identity (Figure 6K). Collectively, our data indicate that TFAP2C functions to 
repress somatic cell fate in the newly specified hPGCLCs as first shown by (Kojima et al., 
2017). In addition, we uncovered new roles, including preventing the TFAP2A+ common 
progenitor cells from crossing Weismann’s barrier to become somatic cells, uniquely 
regulating SOX17 expression at the point of hPGCLC specification from the TFAP2A+ 
progenitors, and finally re-wiring pluripotency in the newly specified hPGCLCs at day 2 of 
aggregate differentiation to a naive-like state similar to primate pre-EPI pluripotency.
DISCUSSION
Specification of hPGCs in the embryo is critical for the generation of functional gametes in 
adults. Therefore, understanding the origin and specification of human germline cells is one 
of the most important events in our fundamental understanding of life, as it defines our 
ability to have children. The Weissman’s barrier was coined to explain DNA transmission 
exclusively through germline cells (Weismann 1893). However, in species that differentiate 
PGCs by induction, the immediate progenitors of the germline differ across the species, and 
as a result, the TF network required for PGC specification has also diverged.
Human embryo attachment culture starting with intact human embryos donated to research 
suggests that hPGC specification, although rare, begins around day 12 of embryo 
development prior to the formation of primitive streak and gastrulation. This is consistent 
with a recent study using OCT4 and SOX17 as hPGC markers (Popovic et al., 2019). Using 
a different approach, we identified hPGCs/hPGCLCs as being triple positive for N/S/T, and 
by using the in vitro differentiation of hPGCLCs from hESCs, we showed that when cells 
co-express N/S/T, they also express the hPGC gene NANOS3. In contrast to the identity of 
specified hPGCs/hPGCLCs that have well-characterized molecular markers, nothing is 
known for the peri-implantation progenitor cells in the germline trajectory. In this study, we 
overcame the challenge by taking advantage of the differentiation time course of hPGCLC 
specification with scRNA-seq and tcURD-based trajectory analysis to trace the trajectory 
from hESCs to hPGCLCs. Different from most single-cell genomics trajectory tracing 
studies, we also managed to compare the trajectories from three genetically different cell 
lines, namely, high germline competency UCLA2, low germline competency UCLA1, and 
TFAP2C−/−UCLA1,which provides us a unique opportunity not only to trace germ cell 
development and characterize the progenitors before germ cell fate is determined but also to 
compare trajectories from different cell lines to pinpoint the potential regulatory circuits 
shared and specific from three scenarios in a stage-specific manner. Our strategy could be 
applied to other complicated biological trajectories without known markers for each stage
Within the germline trajectory after hESCs are induced to differentiate, our data indicate that 
the immediate pluripotent cell precursors exhibit an identity that can be annotated as 
simultaneously pre-implantation (naive) and post-implantation (primed) pluripotency. 
Indeed, transitional pre-implantation embryonic cellular states were recently reported with 
the re-analysis of the scRNA-seq data from Petropoulos et al. (2016) that identified cells 
containing both pre-EPI and primitive endoderm identity (Stirparo et al., 2018). Similarly, 
there is remarkable similarity between ICM and pre-EPI, with only a small number of genes 
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discriminating these different cell types (Blakeley et al., 2015; Petropoulos et al., 2016; 
Stirparo et al., 2018). Therefore, it could be conceivable that along the germline trajectory 
previously unannotated transitional states of pluripotency exist, that share pluripotent 
identities with both naive and primed pluripotent states. Given that this state has not been 
annotated before, we are calling this transitional naive/primed state of pluripotency 
‘‘germinal pluripotency,’’ which is conducive to hPGC specification, amnion differentiation, 
and posterior primitive streak/mesoderm/extra embryonic mesenchyme and trophoblast 
development. This is critical because hPGCLCs are induced from primed state pluripotent 
stem cells, but our data indicate that these primed cells are reverted to a transitional state of 
pluripotency to initiate hPGCLC induction.
With the exposure to BMP4, progenitors for hPGCLCs are specified from germinal 
pluripotent cells. The lineage-primed progenitors transiently expressed amnion and 
gastrulation markers, such as TFAP2A, GATA3, EOMES, and T. In the cyno, the earliest 
cynoPGCs are identified before primitive streak formation at day 11 in the amnion (Sasaki et 
al., 2016). Using microfluidics to create posteriorized 3D-modeled embryos, we could 
identify nascent hPGCLCs in both the amnion as well as the pre-gastrula region 48 h after 
BMP4 exposure (Zheng et al., 2019). BMP4 was essential to create the posteriorized 3D-
modeled embryos with competency to specify hPGCLCs, and similarly, BMP4 is also 
essential to hPGC specification in the 3D-disorganized aggregates used in the current study 
(Sasaki et al., 2015). The tcURD analysis of the 3D-disorganized aggregates suggests that in 
addition to hPGCLCs, BMP4 stimulation creates cells with amnion, gastrulating trophoblast 
and extra embryonic mesenchyme cell identity in the aggregate. Interestingly, 48 h of BMP4 
exposure in the posteriorized 3D embryo models leads to the differentiation of hPGCLCs 
with the highest similarity to the day 2–day 3 hPGCLCs from the disorganized aggregates. 
In contrast, the day 4 hPGCLCs from the disorganized aggregates were more closely related 
to the fully specified ecPGCs from the cyno embryo. Given that this relationship appeared to 
be time dependent, once the technology for maintaining organized 3D embryo models for 
longer periods of time is achieved, it will be valuable to determine whether the hPGCLCs 
from the 3D embryo models progresses closer to fully specified cynoPGC or day 4 
hPGCLCs.
The advantage of the organized 3D embryo models over the disorganized 3D aggregate is 
that the site of nascent hPGCLC specification can be evaluated. In the 3D embryo models, 
hPGCLCs are identified in both the amnion as well as in the pre-gastrula region 48 h after 
BMP4 exposure. Whether hPGCLCs are first specified in the amnion before migrating into 
the pre-gastrula regions of the 3D embryo models remains to be determined. In the porcine 
and mouse peri-implantation embryos, PGCs are identified in the pre-mesendoderm around 
the time of primitive streak formation (Kobayashi et al., 2017), arguing for a pre-gastrula 
origin in these species. Without positional information, our germline trajectory using the 
disorganized aggregates argues for two sites of specification (amnion and gastrula), with 
hPGCLCs being specified from a flexible TFAP2A-positive embryonic progenitor that has 
the potential to give rise to multiple somatic fates.
Specification of hPGCs requires TFAP2C and SOX17 (Chen et al., 2018; Irie et al., 2015; 
Kobayashi et al., 2017; Kojima et al., 2017). However, of these two TFs, only SOX17 can 
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induce hPGCLC fate from pre-mesendoderm cells in the absence of growth factor signaling 
(Kobayashi et al., 2017). SOX17 is also a master regulator of endoderm differentiation. 
Therefore, the mechanism of action for SOX17 in hPGC specification verses endoderm 
identity must be controlled by a germline determinant. Our study demonstrates that prior to 
SOX17 upregulation in the germline trajectory, the immediate progenitors are restrained 
under Weismann’s barrier and that TFAP2C acts at the point of hPGCLC specification to 
upregulate SOX17 in the hPGCLCs. Therefore, without TFAP2C to protect the germline 
integrity, the TFAP2A-positive progenitors ‘‘cross’’ Weismann’s barrier to differentiate into 
gastrulating cells. In contrast, the formation of amnion is unaffected in the absence of 
TFAP2C. Thus, our data illustrate that the first role for TFAP2C in the germline is not to 
induce PGC fate per se but rather to safeguard Weismann’s barrier at the point of hPGC 
specification and to induce SOX17 in the response to BMP4 from a TFAP2A-positive 
progenitor and to establish naive-like pluripotency in the germline (Figure 7).
STAR★METHODS
LEAD CONTACT AND MATERIALS AVAILABILITY
Further information and requests for resources and reagents should be directed to and will be 
fulfilled by the Lead Contact, Amander Clark (clarka@ucla.edu). All unique/stable reagents 
generated in this study are available from the Lead Contact with a completed Materials 
Transfer Agreement.
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Human pre-implantation embryo samples—Use of human embryos in this research 
project followed California State law. This requires review by the Institutional Review Board 
(IRB) and the human embryonic stem cell research oversight committee (ESCRO). These 
committees approve the process of informed consent, and experiments using human 
embryos for research purposes. Patients were not paid for participation, and all donors were 
informed that the embryos would be destroyed as part of the research study and that the 
donated embryos would not be used to make a baby. All research with human embryos in 
this study complied with the principles laid out in the International Society for Stem Cell 
Research. Human blastocysts at day (D6), D7 and D8 post fertilization were used in this 
study (See Table S1). The human blastocysts were thawed using Vit Kit-Thaw (Irvine 
Scientific) according to manufacturer protocol. After thawing, embryos were cultured 
overnight in 5%O2, 6% CO2 at 37oC, and the zona pellucida was removed with Tyrode’s 
acidified solution (Irvine Scientific). Human embryo attachment culture was performed 
following the procedures of (Deglincerti et al., 2016; Shahbazi et al., 2016) using the 
commercially available medias IVC1 (In Vitro Culture 1) and IVC2 from Cell Guidance 
Systems.
Human Fetal Gonad samples—Use of human fetal tissue in this research project was 
reviewed by the UCLA IRB and the project was determined as being exempt under 45 CRF 
46.102(f). Prenatal gonads were obtained from the University of Washington Birth Defects 
Research Laboratory (BDRL), under the regulatory oversight of the University of 
Washington IRB approved Human Subjects protocol combined with a Certificate of 
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Confidentiality from the Federal Government. Human genital ridges were obtained from 
Professor Katja-Layland, Fraunhofer Institute for Interfacial Engineering and Biotechnology, 
Stuttgart, Germany, and Department of Women’s Health, Research Institute for Women’s 
Health, Tubingen, Germany. All consented material was donated anonymously and carried 
no personal identifiers. Developmental age was documented by BDRL as days post 
fertilization using a combination of prenatal intakes, foot length, Streeter’s Stages and 
crown-rump length. All prenatal gonads documented with birth defect or chromosomal 
abnormality were excluded from this study. The human gonad samples used in this study 
include week 4 female and week 5 male conceptus, and a day 53 female fetal ovary and a 
day 59 male fetal testis.
Human ESC culture—hESCs were cultured on mitomycin C-inactivated mouse 
embryonic fibroblasts (MEFs) in hESC media, which is composed of 20% knockout serum 
replacement (KSR) (GIBCO, 10828-028), 100mM L-Glutamine (GIBCO, 25030-081), 1x 
MEM Non-Essential Amino Acids (NEAA) (GIBCO, 11140-050), 55mM 2-
Mercaptoethanol (GIBCO, 21985-023), 10ng/mL recombinant human FGF basic (R&D 
systems, 233-FB), 1x Penicillin-Streptomycin (GIBCO, 15140-122), and 50ng/mL primocin 
(InvivoGen, ant-pm-2) in DMEM/F12 media (GIBCO, 11330-032). The hESCs were split 
every 7 days using Collagenase type IV (GIBCO, 17104-019). All hESC lines used in this 
study are registered with the National Institute of Health Human Embryonic Stem Cell 
Registry and are available for research use with NIH funds. Mycoplasma test (Lonza, 
LT07-418) was performed every month. All experiments were approved by the UCLA 
Embryonic Stem Cell Research Oversight Committee.
METHOD DETAILS
hPGCLC induction—hESCs were dissociated into single cells with 0.05% Trypsin-EDTA 
(GIBCO, 25300-054) and plated onto Human Plasma Fibronectin (Invitrogen, 33016-015)-
coated 12-well-plates at the density of 200,000 cells/well in 2mL/well of iMeLC media, 
which is composed of 15% KSR (GIBCO, 10828-028), 1x NEAA (GIBCO, 11140-050), 
0.1mM 2-Mercaptoethanol (GIBCO, 21985-023), 1x Penicillin-Strep-tomycin-Glutamine 
(GIBCO, 10378-016), 1mM sodium pyruvate (GIBCO, 11360-070), 50ng/mL Activin A 
(Peprotech, AF-120-14E), 3mM CHIR99021 (Stemgent,04-0004), 10mM of ROCKi 
(Y27632, Stemgent, 04-0012-10), and 50ng/mL primocin in Glasgow’s MEM (GMEM) 
(GIBCO, 11710-035). After 24 hr, iMeLCs were dissociated into single cells with 0.05% 
Trypsin-EDTA and plated into ultralow cell attachment U-bottom 96-well plates (Corning, 
7007) at the density of 3,000 cells/well in 200ml/well of hPGCLC media, which is 
composed of 15% KSR (GIBCO, 10828-028), 1x NEAA (GIBCO, 11140-050), 0.1mM 2-
Mercaptoethanol (GIBCO, 21985-023), 1x Penicillin-Streptomycin-Glutamine (GIBCO, 
10378-016), 1mM sodium pyruvate (GIBCO, 11360-070), 10ng/mL human LIF (Millipore, 
LIF1005), 200ng/mL human BMP4 (R&D systems, 314-BP), 50ng/mL human EGF (R&D 
systems, 236-EG), 10mM of ROCKi (Y27632, Stemgent, 04-0012-10), and 50ng/mL 
primocin in Glasgow’s MEM (GMEM) (GIBCO, 11710-035).
Flow cytometry and fluorescence activated cell sorting—Aggregates were 
dissociated with 0.25% trypsin (GIBCO, 25200-056) for 5 min or 0.05% Trypsin-EDTA 
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(GIBCO, 25300-054) for 10 min at 37°C. The dissociated cells were stained with conjugated 
antibodies, washed with FACS buffer (1% BSA in PBS) and resuspended in FACS buffer 
with 7-AAD (BD PharMingen, 559925) as viability dye. The single cell suspension was 
analyzed or sorted for further experiments. The conjugated antibodies used in this study 
include: ITGA6 conjugated with BV421 (BioLegend, 313624, 1:60), ITGA6 conjugated 
with 488 (BioLegend, 313608, 1:60), EPCAM conjugated with 488 (BioLegend, 324210, 
1:60), EPCAM conjugated with APC (BioLegend, 324208, 1:60).
Immunofluorescence—Slides of paraffin-embedded sections were deparaffinized by 
successive treatment with xylene and 100%, 95%, 70% and 50% ethanol. Antigen retrieval 
was performed by incubation with 10mM Tris pH 9.0, 1mM EDTA, 0.05% Tween at 95C for 
40 min. The slides were cooled and washed with 1xPBS (phosphate buffered saline) and 
1xTBS (PBS + 0.2% Tween). The samples were permeabilized with 0.5% Triton X-100 in 
1xPBS, then washed with 1xTBS and blocked with 10% donkey serum in 1xTBS. Primary 
antibody incubation was conducted overnight in 10% donkey serum. Samples were again 
washed with 1xTBS-tween and incubated with fluorescent secondary antibodies at 1:200 for 
45 min, then washed and mounted using with ProLong Gold Antifade Mountant with DAPI 
(ThermoFisher).
For staining of human embryos, attachment cultures were washed once with PBS and fixed 
in 4% PFA (Electron Microscopy Sciences) at room temperature for 20 min followed by 2 
washes in PBS. Attachments were permeabilized in 0.5% Triton-X (Sigma) in PBS for 20 
min at room temperature and then washed once in wash buffer 0.1% Tween-20 (Sigma) in 
PBS. Samples were blocked in 10% normal donkey serum (Jackson ImmunoResearch) in 
0.1% Tween-20/PBS at room temperature and incubated with primary antibody diluted in 
block overnight at 4°C.
Images were taken using LSM 780 Confocal Instrument (Zeiss). The primary antibodies 
used for immunofluorescence in this study include: rabbit-anti-NANOG (Cell Signaling 
Technology, 4903, 1:100), mouse-anti-TFAP2C (Santa Cruz Biotechnology, sc12762, 
1:100), goat-anti-SOX17 (Neuromics, GT15094, 1:100). The secondary antibodies used in 
this study were from Jackson ImmunoResearch Laboratories and Invitrogen. Samples were 
covered in drops of SlowFade Diamond Antifade mountant with DAPI (Invitrogen) and 
imaged on an LSM780 or LSM880 confocal microscope (Zeiss). All images were processed 
by Imaris software.
Single cell RNA-sequencing—Single cell suspension was made from hESCs, iMeLCs, 
day 1 to day 4 aggregates after trypsin treatment. Single cells were washed three to five 
times in PBS supplemented with 0.04% BSA. Single cell suspension was sequenced using 
10X Genomics.
ChIP-sequencing—ChIP-seq of hESCs, iMeLCs, and day 4 aggregates with anti-
TFAP2C antibodies was performed as previously described (Pastor et al., 2018). Two 
biological replicates were performed using about 500k cells. hESCs and iMeLCs were 
dissociated with 0.05% Trypsin-EDTA (GIBCO, 25300-054) for 5 minutes at 37°C, and 
aggregates were dissociated with 0.05% Trypsin-EDTA (GIBCO, 25300-054) for 10 minutes 
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at 37°C, followed by washing twice with PBS, fixed in 1% formaldehyde and flash frozen. 
After thawing, the cells were resuspended in 1 mL of Buffer 1 (10mM Tris-HCl pH8.0, 
0.25% Triton X-100, 10mM EDTA, 0.5mM EGTA, 1x Protease Inhibitors (Roche), 1mM 
PMSF) and incubated at room temperature for 15 min on a rotator. Samples were spun at 
4000 rpm for 5 min and the pellets were wash with 1 mL of Buffer 2 (10mM Tris-HCl 
pH8.0, 200mM NaCl, 10mM EDTA, 0.5mM EGTA, 1x Protease Inhibitors (Roche), 1mM 
PMSF) and resuspended in 650 uL Buffer 3 (10mM Tris-HCl pH8.0, 10mM EDTA, 0.5mM 
EGTA, 1x Protease Inhibitors (Roche), 1mM PMSF) and sonicated with Covaris S2 with the 
following program: Intensity = 5; Cycles/burst = 200; Duty Cycle = 5%; 4 x (30’’ on/30’’ 
off/30’’ on/30’’ off). Sonicated lysate was centrifuged at 14,000rpm for 10 min at 4°C and 
the supernatant was collected into a new tube. 65 µL of the supernatant was saved as input. 
30 µL Protein A Dynabeads (Invitrogen, 10001D) was washed with Dilution Buffer (16.7 
mM Tris-HCl pH8.0, 0.01% SDS, 1.1% Triton X-100, 1.2mM EDTA, 167mM NaCl) three 
times and resuspended in 650 mL Dilution Buffer and added to the samples. The samples 
with beads were rotated for 2 hours at 4°C and the beads were removed by magnetic rack. 
Each sample was split into two parts: one half for Rabbit-anti-TFAP2C (Santa Cruz 
Biotechnology, sc-8977), and the other half for Rabbit-IgG as control. Samples were 
incubated at 4°C overnight. On the second day, 60uL of pre-washed Protein A Dynabeads 
was added to each sample and incubated at 4○C for 2 hours. Samples were placed on 
magnetic rack to remove supernatant and the beads were washed twice with Buffer A 
(50mM HEPES pH7.9, 1% Triton X-100, 0.1% Deoxycholate, 1mM EDTA, 140mM NaCl), 
Buffer B (50mM HEPES pH7.9, 0.1% SDS, 1% Triton X-100, 0.1% Deoxycholate, 1mM 
EDTA, 500mM NaCl), TE and eluted with 150 µL of Elution Buffer (50mM Tris-Cl pH8, 
1mM EDTA, 1% SDS) and incubated at 65○C for 10 min. Samples were placed on magnetic 
rack and ChIP-samples were collected. Both ChIP-samples and input samples were heated 
overnight at 65°C. On the third day, samples were treated with 1.5uL of 10mg/mL RNaseA 
(PureLink RNase A, Invitrogen 12091-021) for 30 min at 65°C and then with 10ul of 
10mg/mL Proteinase K for 2 hours at 56°C. Samples were purified with MinElute PCR 
Purification Kit (QIAGEN, 28006). ChIP-seq libraries were made using Ovation Ultralow 
Systems V2 (NuGEN, 0344) according the instruction. For ChIP-seq of sorted day4 
hPGCLCs using anti-H3K27ac antibodies, about 5000 sorted hPGCLCs were collected and 
ChIP was performed using Low Cell ChIP-Seq Kit (ACTIVE MOTIF, 53084).
QUANTIFICATION AND STATISTICAL ANALYSIS
Experimental design—Single cell RNA-seq libraries were made from tow biological 
replicates of UCLA1, UCLA2 and TFAP2C mutant hESCs, iMeLCs, and day 1 to day 4 
aggregates. ChIP-seq libraries were made from two biological replicates of UCLA1 hESCs, 
iMeLCs, day4 aggregates with anti-TFAP2C antibodies and sorted hPGCLCs with anti-
H3K27ac antibodies. No statistical calculation was used to estimate the sample size. 
Randomization/stratification/blinding were not applicable to these experiments. For flow 
cytometry, at least ten biological replicates were performed. For statistical analysis, mean 
and standard error of the mean and t test were calculated using Graphpad Prism software
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Replicates and data pooling—To call ChIP-seq peaks or display ChIP-seq data in 
Figure 5, all reads from same condition were merged to increase coverage. For single cell 
RNA-seq, two biological replicates were merged after batch correction.
Single-cell RNA-seq data analysis—The reads from single cell RNA-seq were aligned 
to the GRCh38 human reference genome using the Cell Range v.2.2.0 pipeline with default 
parameters (10x Genomes). The generated cell-by-gene unique molecular identifier (UMI) 
count matrix was analyzed using the Seurat R package v.2.3.4. We only kept the cells 
expressing at least 200 genes and genes with expression in at least 3 cells. The cells were 
also filtered by the maximum of 8000 expressed genes and of 20% mitochondrial genes. The 
UMI counts were then normalized for each cell by the total expression, multiplied by 10000, 
and log-transformed. We used Seurat’s default method to identify highly variable genes and 
scale data for regressing out variation from UMI and mitochondrial genes. The scaled data 
with variable genes was used to perform principal component analysis (PCA). The top 50 
principal components were chosen for further analysis, including clustering to identify cell 
populations. UMAPs were calculated by RunUMAP function in Seurat package using top 50 
PCs and min_dist = 0.75.
To do batch correction between two biological replicates, we used Seurat’s canonical 
correlation analysis procedure with default parameter. Briefly, this analysis identifies vectors 
with correlation between datasets and then aligns values along these vectors to reduce the 
variation from batch. The top 30 canonical correlation vectors were used further for 
clustering and UMAP visualization.
Prediction of developmental trajectories using tcURD—The matrix of cell X top 
30 CCA components after batch correction was used to build the tree of lineages by tcURD, 
which is based on URD package (v.1.0.2) in R (Farrell et al., 2018) and do pseudotime 
analysis afterward. We modified URD as tcURD where the diffusion map is calculated by 
destiny package from a sparse distance matrix, with 0 for most of element except those from 
nearest neighbors. Instead of calculating distance from top K nearest neighbors for each cell 
among all other cells, we put a time constraint that nearest neighbors could only come from 
samples at the same or nearby time point for this time series experiment so that we could 
avoid artificial connections of two cells from samples far away from each other in temporal 
order. The pipeline can be found on GitHub (https://github.com/kdyhl/singleCell_tcURD).
Annotation of cell lineage—We re-processed the single cell RNA-seq data in 390 single 
cells of cynomolgus embryos across 13 cell types (GEO: GSE74767). Specifically, we 
identified differentially expressed genes (DEGs) across 13 cell types and generated the 
average expression profiles for 13 cell types based on these DEGs. The average profiles for 
cells at the stage of hPGCLC day4 were also generated in the same way across the segments 
in the URD tree. We next calculated the Pearson Correlation Coefficient (PCC) to evaluate 
the similarity between each lineage in the URD tree and cell type in cyno embryo. The 
similar analysis was carried out to define the cell identity of clusters in ex vivo single cell 
data.
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Signature analysis—We downloaded the processed single cell RNA-seq data of 
cynomolgus (cyno) embryos (GEO: GSE74767, GSE76267) and identified the highly 
expressed genes as signature for each cell type annotated in the original paper compared 
with cells from all different cell identities. Next, we calculated the average expression level 
of each signature set in single cells of germline trajectory and visualized by heatmap. We 
also downloaded the processed single cell RNA-seq data from naive and primed hESCs 
(GEO: GSE76970) and did the similar analysis. Similar analysis was performed in single 
cell RNA-seq data of human synthetic amnion-like cells (hsAM) and PGCLCs (hsPGCLC) 
derived by exposing the H9 hESC line to BMP4 for 48 hours using the synthetic embryonic-
like sac model.
Identification of germline trajectory differentially expressed genes (gtDEGs)—
We defined germline trajectory differentially expressed genes (gtDEGs) as below: (1) we 
identified the pseudotime correlation genes with absolute Pearson correlation coefficient 
(PCC) > 0.2 between pseudotime and gene expression level. (2) we called the differentially 
expression genes between any two time points across germline trajectory using 
FindAllMarkers function in Seurat package with default parameters. (3) the union of geneset 
(1) or (2) were defined as gtDEGs for further analysis.
Motif analysis—To predict the upstream regulators of gtDEGs, we identified the 
enrichment of transcription factor binding motifs in the promoter region (500bp upstream to 
100bp downstream of transcription start site) using findMotifs.pl function in HOMER v4.9 
software with default parameters. Those transcription factors were then filtered by gtDEGs.
Transcription factor (TF) network analysis—Among gtDEGs, we focused on the 
regulatory relationship between transcription factors. We build a TF-TF regulatory network 
based on the presence of transcription factor binding motif at promoter regions (500bp 
upstream to 100bp downstream of transcription start site). The network was visualized in 
Cytoscape v.3.7.1(Shannon et al., 2003). We annotated nodes and edges. The color of node 
represents the pseudotime of its highest expression levels from red to yellow. The size of 
node represents the degree (number of edges). The shape of node represents whether it 
belongs to upstream regulator (triangle: regulator; circle: non-regulator). The arrow of edge 
represents the direction of regulation.
ChIP-seq analysis—FastQC were used to check the quality of the sequencing reads. Then 
reads were mapped to the reference hg19 genome using bowtie by allowing maximal two 
mismatches per reads and take one best hit when the reads can be mapped to multiple places. 
PCR duplciates were removed using SAMtools and ChIPseq tracks were generated with 
deeptools.
Code Availability—Custom scripts used for demultiplexing NGS reads, calculating count 
matrix, visualization for single cell maps, generating differentiation trajectory and 
annotating cell lineages will be made available upon request.
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DATA AND CODE AVAILABILITY
The accession number for the single cell RNA-seq data and ChIP-seq data of key cell types 
including hESCs, iMeLCs, day 1 to day4 aggregates, and sorted hPGCLCs reported in this 
paper is GEO: GSE140021. The pipeline for tcURD can be found on GitHub (https://
github.com/kdyhl/singleCell_tcURD).
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Highlights
• Human germline cell specification begins from a transitional pluripotent state
• Human primordial germ cells are specified from lineage-primed progenitors
• Lineage-primed TFAP2A progenitors have gastrulating and amnion cell 
identity
• TFAP2C regulates SOX17 at the point of human primordial germ cell 
specification
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Figure 1. Tracking the Specification of Human PGCs
(A) Schematic illustration of human embryos used in this study. Frozen embryos at day 5 or 
day 6 post-fertilization were thawed and allowed to recover for 24 h to become day 6 or day 
7, staining or culturing until day 12 as human embryo attachment cultures. Human embryos 
at weeks 4–5 were stained as positive controls for identifying hPGCs.
(B) Human embryo attachment culture at day 12 stained for TFAP2C (purple), SOX17 
(yellow), and NANOG (cyan). Two TFAP2C/SOX17/NANOG triple-positive cells are 
highlighted by a white arrowhead, one of which is enlarged in inset. The number in the 4′,6-
diamidino-2-phenylindole (DAPI) (gray) panel indicates triple-positive cells were identified 
in two day 12 embryos from a total of 26 embryos examined at this time point.
(C) Schematic illustration of hPGCLC differentiation. The UCLA1 and UCLA2 hESC lines 
are induced to differentiate into iMeLCs for 24 h, followed by differentiation as 3D 
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disorganized aggregates for 4 days. Samples were collected at all six time points from each 
hESC line in biological duplicate for 10x Genomics scRNA-seq.
(D) Identification of ITGA6/EPCAM double-positive hPGCLCs by flow cytometry from 
UCLA1 and UCLA2.
(E) Percentage of ITGA6/EPCAM double-positive hPGCLCs isolated from UCLA1 and 
UCLA2 at day 4 of differentiation. ***, indicates statistically significant difference 
comparing more than 10 biological replicates of UCLA1 and UCLA2 at day 4 of 
differentiation (shown is mean and SEM)
(F) Immunofluorescence of TFAP2C (purple), SOX17 (yellow), and NANOG (cyan) in day 
1–4 aggregates from UCLA1 (top) and UCLA2 (bottom). The percentage of TFAP2C/
SOX17/NANOG triple-positive cells at each day is shown. Percentages were calculated from 
five or more biological replicates at each day.
(G and H) UMAP display of all cells in the UCLA1 (G) and UCLA2 (H) dataset in 
biological duplicate (n = 12 samples for each cell line). The expression of NANOS3 
indicates hPGCLCs.
Scale bars: 50 μM. See also Figure S1.
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Figure 2. Highly Germline-Competent hESC Lines Specify More hPGCs within 48 h of BMP4 
Exposure
(A and B) The emergence of TFAP2C/SOX17/NANOG/NANOS3 quadruple-positive cells 
in UCLA1 (A) and UCLA2 (B) by scRNA-seq. UMAP was applied to visualize all single 
cells at each stage. The percentage of TFAP2C/SOX17/NANOG/NANOS3 quadruple-
positive cells (red) is shown. Cutoff: log-transformed-normalized UMI counts of >0.5 for 
TFAP2C, SOX17, NANOG, and NANOS3.
(C and D) URD tree showing the developmental trajectories from hESC and iMeLCs 
through 4 days of aggregate differentiation from UCLA1 (C) and UCLA2 (D). The 
expression of NANOS3 marks the end of the germline trajectory and establishment of 
hPGCLCs in (C) and (D). Cells with endoderm (Endo) identity are outside of the germline 
trajectory, indicating hPGCLCs do not originate from SOX17-positive endoderm. VE/YE, 
visceral/yolk-sac endoderm; EXMC, extra-embryonic mesenchyme; Pre-EPIs, pre-
implantation epiblasts; PostE-EPI, post-implantation early epiblasts; Post-TE, post-
implantation trophectoderm; Gast, gastrulating cells; AMLCs, amnion-like cells (Nakamura 
et al., 2016; Zheng et al., 2019).
See also Figure S2.
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Figure 3. hPGCLC Specification through a Translational Germinal Pluripotent State
(A) The expression patterns of TFAP2C, NANOG, SOX2, POU5F1(OCT4), SOX17, and 
NANOS3 within the germline trajectory of UCLA2. Dash lines outline iMeLCs in germline 
trajectory in (A)–(C).
(B) Relative average expression of signature genes from cynomolgus ICM (inner cell mass), 
Pre-EPIs, PostE-EPIs, and PostL-EPI (post-implantation late epiblast) (Nakamura et al., 
2016) in germline trajectory of UCLA2.
(C) Relative average expression of signature genes from primed and naive hESCs (Messmer 
et al., 2019) in germline trajectory of UCLA2. Signature score bar is same as (B).
(D) Heatmap showing the expression of differentially expressed genes in naive, primed, and 
transitional germinal pluripotent cells.
(E) UMAP displaying the single cells from day 12 human embryonic cells.
(F) Relative expression of signature genes in the 13 epiblasts cells from (E) compared to 
primed and naive hESCs (Messmer et al., 2019) and cells from iMeLCs, day 1 to day 4 cells 
in germline trajectory.
See also Figure S3.
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Figure 4. hPGCLC Specification Involves a Trajectory through a Transient TFAP2A-Positive 
State with a Signature of Both Amnion and Gastrulating Cell Fates
(A and B) The expression patterns of EMOES, T, CDX2, GATA3, and TFAP2A within 
germline trajectory of UCLA1 (A) and UCLA2 (B).
(C) Relative average expression of signature genes from cynomolgus Gast (gastrulating 
cells), ePGC (early PGCs) (Nakamura et al., 2016) and human AMLCs and hPGCLC at day 
2 (Zheng et al., 2019) in germline trajectory of UCLA2.
(D) Expression of TFAP2A, T, EOMES, and MIXL1 in day 1 progenitor population from 
UCLA2.
See also Figure S4.
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Figure 5. TFAP2C Acts Upstream of SOX17
(A) Heatmap showing the differentially expressed genes in the UCLA2 germline trajectory. 
Signature transcription factors (TFs) and predicted regulators are shown for each cluster.
(B) Network showing the regulatory role of TFAP2C and its putative targets in the germline 
trajectory of UCLA2. Red arrows highlight the predicted direct regulation of SOX17 by 
TFAP2C.
(C) Tracks showing the ATAC-seq, TFAP2C ChIP-seq, H3K27ac ChIP-seq, and RNA-seq 
peaks around SOX17 site at each stage.
See also Figure S5.
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Figure 6. TFAP2C Mutant Cells Exit the Germline Trajectory to Become Primitive Streak or 
Amnion-like Somatic Cells
(A) Experimental design comparing scRNA-seq libraries of TFAP2C mutant (T2C−/−) 
hESCs, iMeLCs, day 1, day 2, day 3, and day 4 to wild-type cells of the same genetic 
background (UCLA1).
(B) UMAP showing wild-type and T2C−/− single cells.
(C) Overlay from wild-type UCLA1 (blue) and T2C−/− cells (pink) from each of the six time 
points. Clusters that are largely pink are enriched in mutant cells; clusters that are largely 
blue are enriched in wild-type cells.
(D) NANOS3 expression indicates hPGCLCs.
(E) URD trees showing the differentiation trajectories of all cells combined (wild-type and 
T2C−/− mutant).
(F) Overlay of TFAP2C−/− cells (pink) and wild-type UCLA1 (blue) cells in the URD trees 
illustrates cell trajectories enriched in either mutant (pink) or control cells (blue) cells. 
Percentages of TFAP2C −/− cells in each of the blades of the trajectories.
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(G and H) NANOS3 (G) and SOX17 (H) highlight the germline trajectory ending in 
hPGCLCs (G) and hPGCLCs and VE/YE (H) Red box indicates the mutant-enriched 
trajectory that originates from the common progenitor with hPGCLCs.
(I and J) URD tree showing the expression of somatic (primitive-streak or early amnion 
genes) MIXL1 (I) and T (J), in the TFAP2C−/− enriched blade.
(K) Comparison of cynomolgus Pre-EPI, PostL-EPI, and ePGCs (Nakamura et al., 2016) 
signatures in germline trajectory between wild-type and TFAP2C mutant cells.
See also Figure S5.
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Figure 7. Proposed Model
Human PGCs are specified beginning at day 12. Based on the in vitro germline trajectory, 
we propose that hPGCs originate from a lineage-primed TFAP2A+ progenitor at around day 
11 which is specified from a transitional pluripotent state that shares characteristics with pre- 
and post-implantation epiblasts that we have called ‘‘germinal pluripotency.’’ TFAP2A+ 
progenitors have the potential for hPGC specification and also for differentiation of somatic 
cells, including amnion and gastrulating cells. TFAP2C functions at the critical point of 
hPGC specification to directly regulate expression of the human germ cell fate determinant 
SOX17, while simultaneously preventing germline cells from crossing Weismann’s barrier 
to become somatic cells.
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KEY RESOURCES TABLE
REAGENT or RESOURCE SOURCE IDENTIFIER
Antibodies
Rabbit polyclonal anti-human TFAP2C Santa Cruz Biotechnology Cat#sc-8977; RRID: 
AB_2286995
Mouse monoclonal anti-TFAP2C Santa Cruz Biotechnology Cat#sc-12762; RRID: 
AB_667770
Goat anti-human SOX17 Neuromics Cat#GT15094; RRID: 
AB_2195648
Rabbit anti-human NANOG Cell Signaling Technology Cat#4903; RRID: AB_10829232
Rabbit anti-human-H3K27ac Abcam Cat#ab4729; RRID: 
AB_2118291
BV421 conjugated anti-human/mouse CD49f (ITGA6) BioLegend Cat#313624; RRID: 
AB_2562244
488 conjugated anti-human/mouse CD49f (ITGA6) BioLegend Cat#313608; RRID: AB_493635
Alexa Fluor 488-conjugated anti-human CD326 (EPCAM) BioLegend Cat#324210; RRID: AB_756084
APC-conjugated anti-human CD326 (EPCAM) BioLegend Cat#324208; RRID: AB_756082
Biological Samples
Human pre-implantation embryos at day 6, day 7 and day 8 
post-fertilization
Surplus embryos from in vitro fertilization 
clinics in the United States.
N.A.
Human week 4 female and week 5 male genital ridges Fraunhofer Institute for Interfacial 
Engineering and Biotechnology, Germany
N.A.
Human day 53 female fetal ovary and day 59 male fetal 
testis
University of Washington Birth Defects 
Research Laboratory
N.A.
Chemicals, Peptides, and Recombinant Proteins
CHIR99021 Stemgent Cat# 04-0004
Y27632 Stemgent Cat# 04-0012-10
Recombinant Human FGF basic Protein R&D systems Cat#233-FB
Recombinant Activin A Peprotech Cat# AF-120-14E
Recombinant human LIF Millipore Cat# LIF1005
Recombinant human BMP4 R&D systems Cat#314-BP
Recombinant human EGF R&D systems Cat#236-EG
Critical Commercial Assays
Ovation Ultralow System V2 NuGEN Cat#0344
Low Cell ChIP-Seq Kit ACITVE MOTIF Cat#53084
VIT KIT Thaw Irvine Scientific Cat#90137-SO
IVC medium Cell Guidance Systems Cat #M11-6
IVC medium Cell Guidance Systems Cat# M12-6
Deposited Data
Single cell RNA-seq data This paper GSE140021
ChIP-seq data This paper GSE140021
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REAGENT or RESOURCE SOURCE IDENTIFIER
Single cell RNA-seq data Zheng et al., 2019 GSE134571
Single cell RNA-seq data Nakamura et al., 2016 GSE74767
Single cell RNA-seq data Sasaki et al., 2016 GSE76267
ATAC-seq data Chen et al., 2018 GSE120648
ChIP-seq data Pastor et al., 2018 GSE101074
Experimental Models: Cell Lines
UCLA1 Diaz Perez et al., 2012 N/A
UCLA2 Diaz Perez et al., 2012 N/A
UCLA1 TFAP2C−/− line 1 Pastor et al., 2018 N/A
Software and Algorithms
BD FACSDIVA software BD Biosciences N/A
FLOWJO software FLOWJO N/A
GraphPad Prism software GraphPad N/A
Photoshop software Adobe N/A
Illustrator software Adobe N/A
R https://www.R-project.org N/A
HOMER Motif Analysis http://homer.ucsd.edu/homer/motif/ N/A
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